Comparison
Omega-3 (DHA/EPA) vs Nicotinamide Riboside (NR)
Omega-3 (DHA/EPA)
Essential fatty acids critical for brain structure and function. DHA comprises ~40% of brain polyunsaturated fatty acids.
Nicotinamide Riboside (NR)
NAD+ precursor — the most-studied form for direct NAD+ elevation in humans. Branded as Niagen.
| Field | Omega-3 (DHA/EPA) | Nicotinamide Riboside (NR) |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 1000–3000mg | 250–1000mg |
| Half-life | 24h | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEA |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 5200 | 250 |
The comparison in plain English
Auto-generated from dataOmega-3 (DHA/EPA) and Nicotinamide Riboside (NR) are both in the neuroprotective category respectively. Omega-3 (DHA/EPA) Essential fatty acids critical for brain structure and function. Nicotinamide Riboside (NR) NAD+ precursor — the most-studied form for direct NAD+ elevation in humans.
Bottom line
Omega-3 (DHA/EPA) (evidence A, safety 5/5) matches the evidence base of Nicotinamide Riboside (NR) (evidence A, safety 5/5). Omega-3 (DHA/EPA) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Omega-3 (DHA/EPA) if
Omega-3 (DHA/EPA) is the better fit when your goal aligns with its mechanism (DHA (docosahexaenoic acid) is a structural component of neuronal cell membranes, maintaining fluidity and supporting receptor function) and the dose range (1000–3000mg) suits your protocol. Half-life is 24h.
Choose Nicotinamide Riboside (NR) if
Nicotinamide Riboside (NR) is the better fit when your goal aligns with its mechanism (Precursor in the NAD+ salvage pathway via NRK1 and NRK2 enzymes that phosphorylate NR to NMN, which then converts to NAD+) and the dose range (250–1000mg) suits your protocol. Half-life is —h.